Plasma Metabolomics and Olink Proteomics Profiling Predict Outcome of Fufang Duzhong Jiangu Granules in Kashin-beck Disease
Authors:
Preprint
- 5 January 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Objectives To investigate predictive biomarkers that could be used to identify patients’ response to treatment, plasma metabolomics and proteomics analyses were performed in Kashin-beck disease (KBD) patients treated with Fufang Duzhong Jiangu Granules (FDJG). Methods Plasma were collected from twelve KBD patients before treatment and one month after FDJG treatment. LC-MS was employed for plasma metabolomics profiling, while the olink inflammatory protein panel was used for obtaining inflammatory protein profiles. Patients were classified into responders and non-responders based on drug efficacy after one-month treatment. Enrichment analyses of differential metabolites and proteins of the responders at baseline and after treatment were conducted to study the mechanism of drug action. Differential metabolites and proteins between the two groups were screened as biomarkers to predict drug efficacy. ROC curve was used to evaluate the prediction accuracy of biomarkers. Results The changes of metabolites and inflammatory proteins in responders after treatment reflected the mechanism of FDJG treatment for KBD, which may act on glycerophospholipid metabolism, D-glutamine and D-glutamate metabolism, nitrogen metabolism, and NF-kappa B signaling pathway. We identified three metabolites as potential predictors: N-undecanoylglycine, beta-aminopropionitrile, and PC (18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)). For inflammatory protein, IL-8 was identified as predictive biomarkers to detect responders. Additionally, IL-8 persisted significant in comparison responders to non-responders after one month of therapy. Combined use of these four biomarkers had high predictive ability (AUC = 0.972). Conclusion Metabolomics and olink proteomics provide new insights for precision therapy. In our study, IL-8 may be a novel stable potential biomarker for predicting the efficacy of FDJG in KBD treatment.Keywords
All Related Versions
This publication has 37 references indexed in Scilit:
- The Prevalence of Kashin-Beck Disease in China: a Systematic Review and Meta-analysisBiological Trace Element Research, 2022
- Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platformsProteomics, 2022
- Extensive cytokine analysis in synovial fluid of osteoarthritis patientsCytokine, 2021
- Meta-analysis of Association Studies of Selenoprotein Gene Polymorphism and Kashin-Beck Disease: an Updated Systematic ReviewBiological Trace Element Research, 2021
- The effectiveness of treatments for Kashin–Beck disease: a systematic review and network meta-analysisClinical Rheumatology, 2019
- The Effect of β-Aminopropionitrile on Skeletal Micromorphology and OsteogenesisCalcified Tissue International, 2018
- Reliability and validation of the joint dysfunction index as a new assessment instrument for therapeutic efficacy for Kashin-Beck diseaseClinical Rheumatology, 2016
- Integrative analysis of genome-wide association studies and gene expression profiles identified candidate genes for osteoporosis in Kashin-Beck disease patientsOsteoporosis International, 2015
- Role of inflammation in the process of clinical Kashin-Beck disease: latest findings and interpretationsInflammation Research, 2015
- Growth‐related oncogene α induction of apoptosis in osteoarthritis chondrocytesArthritis & Rheumatism, 2002